Skip to main content
Anders Carlson, MD, Endocrinology, St. Louis Park, MN

Anders L Carlson MD

Diabetes, Lipid Metabolism


Assistant Professor, Medicine, University of Minnesota Medical School, Minneapolis

Join to view full profile
  • 1665 Utica Ave SSte 100St. Louis Park, MN 55416

  • Phone+1 952-541-2500

Dr. Carlson is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Vermont Medical Center
    University of Vermont Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2008 - 2010
  • Hennepin Healthcare
    Hennepin HealthcareResidency, Internal Medicine, 2005 - 2008
  • University of Minnesota Medical School
    University of Minnesota Medical SchoolClass of 2005

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 2010 - 2027
  • WI State Medical License
    WI State Medical License 2010 - 2027
  • VT State Medical License
    VT State Medical License 2008 - 2010
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Fast‐Acting Insulin Aspart Versus Insulin Aspart in the Setting of Insulin Degludec‐Treated Type 1 Diabetes: Efficacy and Safety from a Randomized Double‐Blind Trial  
    John B Buse, Anders L Carlson, Diabetes, Obesity and Metabolism

Lectures

  • Clinical Aspects of Glycemic Control: From Hypoglycemia to Novel Therapeutic Pathways 
    ENDO 2019 - New Orleans, LA - 3/25/2019

Press Mentions

  • Should ‘Time in Tight Range’ Be the Primary Diabetes Goal?
    Should ‘Time in Tight Range’ Be the Primary Diabetes Goal?March 25th, 2025
  • Remote Diabetes Management Using CGM and Telemedicine Visits Can Improve Glycemic Control
    Remote Diabetes Management Using CGM and Telemedicine Visits Can Improve Glycemic ControlSeptember 22nd, 2021
  • Medtronic Touts Trial Results for InPen Smart Insulin Pen, Extended Infusion System
    Medtronic Touts Trial Results for InPen Smart Insulin Pen, Extended Infusion SystemJune 28th, 2021

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: